Sponsor or institution
Clinical trials and research at Intra-IMMUSG Pte Ltd
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Intra-IMMUSG Pte Ltd that are recruiting, at sites in 2 countries (most in Malaysia (1), Singapore (1)). By phase: Phase 2/3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
PRL3-zumab for neovascular (wet) age-related macular degeneration
This trial tests whether three intravenous doses of PRL3-zumab given every two weeks can help people with neovascular (wet) age-related macular degeneration who have not responded to at least two standard intravitreal treatments.
-
PRL3-zumab treatment for advanced solid cancers
This Phase II/III study will test whether IV PRL3-zumab (6 mg/kg) given every two weeks can control tumors and is safe in adults with advanced solid cancers.
Quick answers
How many clinical trials run by Intra-IMMUSG Pte Ltd are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Malaysia (1 trial), Singapore (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.